Delta 9 Cannabis Investor Dashboard

Company Overview:

Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9’s shares trade on the TSX Venture Exchange under the symbol “NINE” and on the OTCQX under the symbol VRNDF.

[stock_market_chart symbol=”NINE.V” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]

Key Share Information:

Current Share Price#N/A
Market Capitalization (in Millions)#N/A
Last Quarter (Share Data)3/31/2019
Shares Outstanding (in Millions)86.76
Options (in Millions)7.20
Warrants (in Millions)9.15
Fully Diluted (in Millions)103.11
Enterprise Value (in MIllions)#N/A
TTM Revenue$15.17
TTM Growth Margin %80.14%
TTM Operating Expenses$26.02
TTM OCF-$6.25
P/S TTM#N/A
P/S (Last Quarter Run Rate)#N/A

Key Balance Sheet Information (in Millions $CAD):

 CYQ4'16CYQ1'17CYQ2'17CYQ3'17CYQ4'17CYQ1'18CYQ2'18CYQ3'18CYQ4'18CYQ1'19
Cash$0.01$0.00$0.00$0.01$23.55$21.25$13.91$23.21$16.23$7.76
Biological Assets$0.13$0.22$0.55$1.66$3.79$6.18
Inventory$0.38$0.46$0.34$2.41$2.57$5.19
Total Assets$0.03$0.02$0.08$0.04$25.04$23.98$22.56$37.87$45.98$65.35
Net Tangible Assets$0.03$0.02$0.08$0.04$25.04$23.98$22.56$37.87$45.98$65.35
Intangibles/Goodwill
Total Liabilities$0.15$0.17$0.25$0.30$0.48$0.59$0.50$1.31$10.67$19.28

Key Operating Items (Quarterly in Millions $CAD):

 CYQ4'16CYQ1'17CYQ2'17CYQ3'17CYQ4'17CYQ1'18CYQ2'18CYQ3'18CYQ4'18CYQ1'19
Revenue$0.94$0.33$0.72$1.25$7.57$5.63
Change in Fair Value of Biologial Assets$0.13$0.09$0.331.224.33$4.06
Gross Margin$0.44$0.20$0.661.535.74$4.22
Marketing and Sales$0.38$0.12$0.270.302.08$0.97
Investor Relations$0.39$0.590.832.26$0.03
Total Operating Expenses$0.11$0.20$0.02$0.08$3.16$2.13$2.853.7614.24$5.17
Operating Cash Flow (Quarterly)-$0.47-$0.05-$0.02-$4.60-$3.29-4.44-0.13$1.60
Investing Cash Flow (Quarterly)$0.00$0.00-$1.47-$4.31-2.50-12.24$16.35
Financing Cash Flow (Quarterly)$0.48$0.05$0.02$29.50$0.2616.245.39-$19.10

Listing Statement

Share
Tweet
Share